IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FOCA', EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.032
AS - Asia 5.598
EU - Europa 4.693
SA - Sud America 1.107
Continente sconosciuto - Info sul continente non disponibili 452
AF - Africa 182
OC - Oceania 22
AN - Antartide 1
Totale 24.087
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.693
SG - Singapore 1.982
CN - Cina 1.595
IT - Italia 1.161
BR - Brasile 900
DE - Germania 695
UA - Ucraina 682
HK - Hong Kong 681
VN - Vietnam 417
PL - Polonia 396
GB - Regno Unito 374
FI - Finlandia 328
FR - Francia 271
RU - Federazione Russa 236
BD - Bangladesh 228
TR - Turchia 199
CA - Canada 175
IE - Irlanda 156
IN - India 143
NL - Olanda 96
MX - Messico 78
AR - Argentina 67
SE - Svezia 66
JP - Giappone 62
ES - Italia 46
ZA - Sudafrica 46
ID - Indonesia 43
BF - Burkina Faso 41
AT - Austria 38
IQ - Iraq 38
CZ - Repubblica Ceca 32
EC - Ecuador 30
CO - Colombia 25
PK - Pakistan 25
SA - Arabia Saudita 24
VE - Venezuela 22
AU - Australia 20
CL - Cile 20
CR - Costa Rica 20
JM - Giamaica 20
BE - Belgio 18
LT - Lituania 18
JO - Giordania 17
AE - Emirati Arabi Uniti 16
UZ - Uzbekistan 16
NG - Nigeria 15
EU - Europa 14
MA - Marocco 13
PY - Paraguay 13
CH - Svizzera 12
EG - Egitto 12
IL - Israele 12
PE - Perù 12
KE - Kenya 11
TN - Tunisia 11
TH - Thailandia 10
AZ - Azerbaigian 9
MY - Malesia 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
HN - Honduras 8
KZ - Kazakistan 8
PH - Filippine 8
BO - Bolivia 7
GR - Grecia 6
GT - Guatemala 6
IR - Iran 6
KR - Corea 6
LK - Sri Lanka 6
BG - Bulgaria 5
DK - Danimarca 5
EE - Estonia 5
NP - Nepal 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
BH - Bahrain 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
LV - Lettonia 4
MK - Macedonia 4
SV - El Salvador 4
UG - Uganda 4
AM - Armenia 3
CG - Congo 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AL - Albania 2
Totale 23.609
Salva come PNG Salva come JPEG
Città #
Ashburn 1.212
Singapore 1.040
Fairfield 837
San Jose 737
Hong Kong 676
Woodbridge 616
Jacksonville 526
Houston 425
Chandler 392
Warsaw 387
Council Bluffs 386
New York 373
Seattle 366
Beijing 348
The Dalles 343
Wilmington 339
Ann Arbor 317
Cambridge 300
Los Angeles 281
Princeton 268
Dallas 221
Helsinki 217
Lauterbourg 169
Nanjing 166
Istanbul 161
Munich 156
Dublin 153
Ho Chi Minh City 147
Brescia 146
Columbus 109
Milan 98
Santa Clara 95
Buffalo 92
San Francisco 86
Chicago 81
Des Moines 81
Phoenix 78
Shanghai 78
Moscow 76
São Paulo 75
Orem 74
Hanoi 69
Redondo Beach 65
Dearborn 62
Tokyo 59
London 53
Nanchang 53
Tianjin 52
Frankfurt am Main 49
Montreal 48
San Diego 48
Changsha 47
Turku 47
Toronto 46
Jinan 45
Shenyang 45
Brooklyn 43
Atlanta 42
Denver 40
Ouagadougou 40
Rome 38
Hebei 37
Nuremberg 37
Chennai 36
Lancaster 34
Boardman 32
Amsterdam 31
Boston 29
Hangzhou 29
Rio de Janeiro 28
Belo Horizonte 26
Poplar 26
Zhengzhou 26
Jiaxing 25
Johannesburg 24
Manchester 24
Mexico City 24
Stockholm 24
Brno 23
Charlotte 23
Düsseldorf 23
Haiphong 23
Bologna 21
Mumbai 21
Naples 21
Newark 21
Ningbo 20
Vienna 20
Romola 19
Dhaka 18
Kunming 18
North Bergen 18
Paris 18
Salt Lake City 18
Taizhou 18
Washington 18
Brasília 17
Brussels 17
Curitiba 17
Kingston 17
Totale 14.640
Salva come PNG Salva come JPEG
Nome #
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 608
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 517
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 286
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 259
Calculated Decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm 257
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 253
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 237
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 235
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 228
Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy 225
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 212
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 210
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 210
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 210
Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa 206
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: A substudy of the NEAT001/ANRS143 randomised trial 199
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 198
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 193
Virological effectiveness and CD4+ T-cell increase over early andlate courses in HIV infected patients on antiretroviral therapy: focus on HCV andanchor class received 188
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 187
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 183
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 180
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART 179
Repurposed antiviral drugs for COVID-19 — InteriM WHO solidarity trial results 179
UVA1 phototherapy as a treatment option for plaque psoriasis in HIV-positive patients 176
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 175
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 175
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 174
DTG prescribing patterns in PLWH ≥65 years: the impact of 2DR and weight gain 174
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 172
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 172
Coinfezione HIV/HBV in Burkina Faso, Africa Occidentalele 170
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 170
Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? 169
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 169
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 167
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 167
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy 165
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 165
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 164
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre study 163
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 160
Elderly women with human immunodeficiency virus infection: is there an effect of the virus on neuropsychological prolife? 158
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 157
Phenotypic and genotypic evaluation of slime production by conventional and molecular microbiological techniques 157
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 157
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy 154
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort 153
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 153
Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study. 150
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir 150
Adverse events associated to HAART in Burkina Faso 149
High prevalence of radiological vertebral fractures in HIV-infected males 148
Management of neurocysticercosis in Northern Italy: presentation of 11 cases and review of the literature on an emerging infection 148
Malaria prophylaxis. A comprehensive review 147
Sexuality, pregnancy and procreation desire among HIV+ patients in Ouagadougou, Burkina Faso 146
Abacavir adverse reactions related with HLA-B*57: 01 haplotype in a large cohort of patients infected with HIV 146
Perinatally HIV-Infected Youths After Transition from Pediatric to Adult Care, a Single-Center Experience from Northern Italy 145
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 145
Malaria and HIV in adults: When the parasite runs into the virus 145
Coming home to be cared. Emigration and antiretroviral treatment in the Nanoro health district, Burkina Faso. 143
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 142
Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of Hepatocellular carcinoma (HCC): a single-centre study 142
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover 142
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 141
Drug-specific risk of adverse events onset related to HAART in a resource-limited setting from 2001 to 2009: the experience of 3 medical centers in Burkina Faso 140
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: An Italian randomized clinical trial 139
HIV/HBV and HIV/HCV co-infection in Burkina Faso, West Africa 137
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 137
Qualitative and quantitative analysis of mortality and morbidity at the health facilities in the rural district of Nanoro, Burkina Faso 136
The use of ultrasonography, transient elestography, APRI and FIB-4 to measure liver steatosis and fibrosis in HIV-positive patients not co-infected with hepatitis viruses with hypertransaminasemia of unknown origin on HAART 134
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 132
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 132
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 131
Disengagement and reengagement of HIV continuum of care in a single center cohort in northern Italy 131
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? 129
Unboosted Atazanavir for Treatment ofHIV Infection: Rationale and Recommendations for Use 127
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 127
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience 127
Coming home to be cared. Emigration and antiretroviral treatment in the Nanoro health District, Burkina Faso 126
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic 126
International migrations and HIV care in the rural District of Nanoro, Burkina Faso 126
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: Results of a 3-year cohort study 125
Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. 124
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 123
An HIV elite controller patient carrying the homozygous H63D variant in the homeostatic iron regulator gene: A case report 123
Virological Effectiveness of Dolutegravir Plus Darunavir in People with Multi-Drug-Resistant HIV: Data from the PRESTIGIO Registry 122
Pregnancy related immune-deficit in HIV-infected pregnant women in resource-limited countries. Implications for HAART initiation 122
Immunological Evolution of a Cohort of HIV-2 Infected Patients: Peculiarities of an Underestimated Infection 121
Amebiasi e infezione da amebe a vita libera 121
The good, the bad and the ugly: Determinants of antiretroviral-associated toxicities 121
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 120
Infezioni intestinali da protozoi e tricomoniasi 119
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 119
A 2021 update on syphilis: Taking stock from pathogenesis to vaccines 118
Monitoring the toxicity related to HAART from 2001 to 2009 in Burkina Faso: clinical adverse events vs. laboratori adverse events: prevalence, grading and outcome 117
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 116
Chronic Hepatitis C Cascade of Care in Prisoners—Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy 116
User fees and compliance to HAART in Ouagadougou, Burkina Faso 116
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian “GEPPO” Cohort 115
Totale 16.699
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022935 0 0 0 77 42 69 74 88 66 133 102 284
2022/20231.177 156 19 23 80 111 290 5 122 217 10 77 67
2023/20241.435 90 27 123 106 67 269 63 62 313 24 54 237
2024/20253.524 41 36 41 444 321 328 269 156 425 345 670 448
2025/20267.561 690 855 509 1.123 931 538 1.041 273 443 597 357 204
2026/20272.564 435 604 627 898 0 0 0 0 0 0 0 0
Totale 24.087